- Home
- PHVS vs AMSF Comparison
PHVS vs AMSF Comparison
Compare PHVS & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- AMSF
- Stock Information
- Founded
- PHVS 2015
- AMSF 1985
- Country
- PHVS Netherlands
- AMSF United States
- Employees
- PHVS N/A
- AMSF N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- PHVS Health Care
- AMSF Finance
- Exchange
- PHVS Nasdaq
- AMSF Nasdaq
- Market Cap
- PHVS 1.0B
- AMSF 984.1M
- IPO Year
- PHVS 2021
- AMSF 2005
- Fundamental
- Price
- PHVS $18.54
- AMSF $51.24
- Analyst Decision
- PHVS Strong Buy
- AMSF Buy
- Analyst Count
- PHVS 5
- AMSF 2
- Target Price
- PHVS $40.60
- AMSF $59.50
- AVG Volume (30 Days)
- PHVS 66.5K
- AMSF 134.8K
- Earning Date
- PHVS 11-13-2024
- AMSF 02-19-2025
- Dividend Yield
- PHVS N/A
- AMSF 2.90%
- EPS Growth
- PHVS N/A
- AMSF N/A
- EPS
- PHVS N/A
- AMSF 3.21
- Revenue
- PHVS N/A
- AMSF $315,182,000.00
- Revenue This Year
- PHVS N/A
- AMSF N/A
- Revenue Next Year
- PHVS N/A
- AMSF $0.88
- P/E Ratio
- PHVS N/A
- AMSF $15.88
- Revenue Growth
- PHVS N/A
- AMSF 2.81
- 52 Week Low
- PHVS $15.37
- AMSF $41.97
- 52 Week High
- PHVS $33.00
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- PHVS 42.23
- AMSF 32.75
- Support Level
- PHVS $18.18
- AMSF $50.61
- Resistance Level
- PHVS $19.88
- AMSF $51.98
- Average True Range (ATR)
- PHVS 1.17
- AMSF 0.94
- MACD
- PHVS 0.08
- AMSF -0.16
- Stochastic Oscillator
- PHVS 23.92
- AMSF 14.93
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.